(NASDAQ: KRRO) Korro Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.96%.
Korro Bio's earnings in 2026 is -$88,417,000.On average, 12 Wall Street analysts forecast KRRO's earnings for 2026 to be -$77,776,498, with the lowest KRRO earnings forecast at -$164,183,004, and the highest KRRO earnings forecast at -$49,243,036. On average, 9 Wall Street analysts forecast KRRO's earnings for 2027 to be -$82,512,455, with the lowest KRRO earnings forecast at -$159,383,951, and the highest KRRO earnings forecast at -$29,466,716.
In 2028, KRRO is forecast to generate -$72,186,391 in earnings, with the lowest earnings forecast at -$161,137,451 and the highest earnings forecast at -$28,181,255.